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In Kenya, leaves and roots from Croton macrostachyus are used as a traditional medicine for infectious diseases such as typhoid and
measles, but reports on possible antimicrobial activity of stem bark do not exist. In this study, the antibacterial and antifungal
effects of methanol, ethyl acetate and butanol extracts, and purified lupeol of C. macrostachyus stem bark were determined
against important human gram-negative pathogens Escherichia coli, Salmonella typhi, Klebsiella pneumoniae, and Enterobacter
aerogenes, gram-positive Listeria monocytogenes, and a fungus Candida albicans. The most promising broad scale antimicrobial
activity against all the studied pathogens was shown by the ethyl acetate extract. The ethyl acetate extract induced the zone of
inhibition between 10.1 ± 0.6mm and 16.0 ± 1.2mm against S. typhi, E. coli, K. pneumoniae, E. aerogenes, and L. monocytogenes
with weaker antimicrobial activity against C. albicans (zone of inhibition: 5.6 ± 1.0mm). The antibiotic controls (amoxicillin,
ciprofloxacin, ampicillin, benzylpenicillin, clotrimazole, and cefotaxime) showed antimicrobial activity with zones of inhibition
within 13.4 ± 0.7–22.1 ± 0.9mm. The ethyl acetate extract had MIC in the range of 125–250mg/mL against all the studied
bacteria and against C. albicans MIC was 500mg/mL. The present results give scientific evidence and support the traditional use
of C. macrostachyus stem bark as a source for antimicrobials. We show that C. macrostachyus stem bark lupeol is a promising
antimicrobial agent against several important human pathogens.
1. Background
About 80% of the rural population in Sub-Saharan Africa
depends on traditional herbal remedies for primary health
care and veterinary use [1]. In many developing countries
antibiotic resistance, adverse drug reactions, and the high
costs of antimicrobials have made management of infectious
diseases ineffective [2, 3]. Natural products of higher plants
may be a source of new antimicrobial agents with possibly
novel mechanisms of action [3, 4].
The plant Croton macrostachyus has been traditionally
used to treat diseases in Kenya [5]. Stem barks and twigs of
Croton spp. contain fatty acids, lupeol, and betulin [6];
saponins and resins are usually found in the seeds [6]
and crotepoxide and crotomacrine in fruits [7]. Roots con-
tain chalcone and secondary metabolites such as 3𝛽-ace-
toxy taraxer-14-en-28-oic acid, trachyloban-19-oic acid, tra-
chyloban-18-oic acid, neoclerodan-5,10-en-19,6𝛽;20,12-diolide,
3𝛼,19-dihydroxytrachylobane, and 3𝛼,18,19-trihydroxytrachy-
lobane [8].
Several hydroalcoholic C. macrostachyus stem bark
extracts have been tested against a clinical strain of Neisseria
gonorrhoeae [9] with the minimum inhibitory concentration
(MIC) of 125–250mg/mL. There are both negative and
positive reports on the antibacterial activity of methanol
extracts from C. macrostachyus leaves [5, 10]. Contrasting
results could be attributed to the locality of plant species, parts
used, time of collection, storage conditions, and methods of
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analysis [11]. In the present study we tested the antimicrobial
activity of methanol, ethyl acetate, and isobutanol extracts
from C. macrostachyus stem bark against human pathogenic
E. coli, Salmonella typhi, Klebsiella pneumoniae, Enterobacter
aerogenes, Listeria monocytogenes, and Candida albicans.The
ethyl acetate extract was submitted for further purification
using column chromatography fractionation and the purified
compound was identified by NMR spectroscopy. Agar well
diffusion method [12] was used to determine the zones of
inhibition and the MIC values.
2. Materials and Methods
2.1. Plant Collection and Extraction. C. macrostachyus stem
bark was collected from Baraton Community in Nandi
District of Kenya from the nature preserve of the University
of Eastern Africa, Baraton, Kenya. Sample of plant was
deposited in the herbarium at the Department of Biological
Sciences, University of Eastern Africa, Baraton, and the
National Museums of Kenya for identification.
2.2. Preparation of the Bark Extract. The fresh stem bark was
cut into small pieces using a pen knife. The cut bark was air-
dried in a shaded area for three weeks.The air-dried bark was
powdered using a mechanized hand grinder. The powdered
material (500 g) was soaked into absolute methanol, ethyl
acetate, or isobutanol for 24 hours. The soaked extract was
separated from the plant residue using a Buchner funnel.The
extract was separated from the solvent by a rotary evaporator
(Rotavapor R300) below 40∘C. Thin layer chromatography
was used to detect the presence of polar compounds. In order
to isolate pure compounds from the ethyl acetate extract silica
gel column chromatography was employed. The column was
washed with hexane and toluene and the sample eluted and
collected with ethyl acetate. The eluted samples were dried
in air and crystallized. The crystals were analyzed by NMR
spectroscopy.
Each plant extract was then dissolved in dimethyl sul-
foxide (DMSO, Rankem, India) to the concentration of
500mg/mL to determine the zones of inhibition. For themin-
imum inhibitory concentrationmeasurements the stock solu-
tion (500mg/mL) was serially diluted to give the concentra-
tions of 250mg/mL, 125mg/mL, 62.5mg/mL, 31.25mg/mL,
15.63mg/mL, 7.81mg/mL, 3.90mg/mL, and 1.95mg/mL.
2.3. NMR Analysis. The crystallized ethyl acetate extract was
dissolved in deuterated chloroform (CDCl
3
) and transferred
into a 5mm NMR tube. Subsequent NMR analysis was
carried out at RTonBrukerAvanceAV400 spectrometerwith
5mm Automatic Tuning and Matching (ATM) Multinuclear
Broadband Observe (BBO) probe including 1H and 13C
experiments. All experiments were referenced to the solvent
peak.
2.4. Bacterial Strains and Culture Conditions. The following
bacterial strains were used for the study: Escherichia coli
ATCC 25922, Salmonella typhi ATCC 2202, Klebsiella pneu-
moniae ATCC 1583380, Enterobacter aerogenesMTCC 2990,
Listeria monocytogenes ATCCEK 138, and Candida albicans
ATCC 14053. The microbial freeze-dried strains were stored
in the deposit of the University of Baraton and regenerated
in brain heart infusion broth (HiMedia Laboratories Pvt.,
Ltd., Mumbai, India). The organisms were then cultured
overnight on Mu¨eller-Hinton agar (HiMedia Laboratories
Pvt., Ltd., Mumbai, India). For the antimicrobial experiments
one colony of each microbial strain was inoculated from
the agar into 5mL of tryptone soya broth (TSB) (HiMedia
Laboratories Pvt., Ltd.,Mumbai, India).Themicrobial strains
were cultured overnight, bacterial strains at 37∘C, and C.
albicans at 30∘C.The cultures were followed bymeasuring the
absorbance at 𝐴
625 nm. For the antimicrobial experiment the
densities of the cultures were adjusted to the 𝐴
625 nm value of
0.1 against a TSB control using a spectrophotometer.
2.5. Agar Well Diffusion Method. Antimicrobial activity of
the extracts was analyzed using agar well diffusion assay
according to the technique described by Taye et al. [12].
Several plates of Mu¨eller-Hinton agar were made and labeled
according to the extract and by the concentration, including a
negative DMSO control and the following positive antibiotic
controls: for S. typhi, E. coli, K. pneumoniae, and E. aerogenes
antibiotics used were amoxicillin and ciprofloxacin. For
L. monocytogenes antibiotic controls were ampicillin and
benzylpenicillin and for C. albicans antibiotic controls were
clotrimazole and cefotaxime. The selection of antibiotics and
antifungal agents was based on the general knowledge of the
typical susceptibilities of the chosen indicator microorgan-
isms, and the expected sensitivities were confirmed during
the actual experiments.
Then 0.6% soft agar (Bacto Agar, HiMedia Laboratories
Pvt., Ltd., Mumbai, India) (2mL) was introduced into tubes
and sterilized by autoclaving. After cooling the soft agar tubes
were placed in a water bath at 48∘C. 200𝜇L of organism
was mixed with 2mL of the soft agar and the mixture was
aseptically transferred to the surface of the solid Mu¨eller-
Hinton agar plate and allowed to solidify for 40 minutes. In
addition to control wells three sample wells were drilled in
the extract concentration-labeled agar plate using a sterilized
6mm cork borer, giving 3 replicates per plate. The extract
(75 𝜇L) was transferred to each of the 3 wells per plate. The
zones of inhibition (mm) were recorded frommeasurements
of the clear zones around the agar wells. The minimum
inhibitory concentrations were determined using the tube
dilutionmethod. Results for antimicrobial testswere reported
asmeans ± standard deviation (SD).Minimal inhibitory con-
centrationwas the lowest concentration showing clear zone of
inhibition. For each solvent extract and each organism, three
different experiments were conducted, giving nine readings
per extract for each organism. Positive antibiotic controls
were included in the assays at their recommended effective
concentrations.
3. Results
3.1. Growth Inhibition. Results of the growth inhibition
experiments are shown in Table 1. The ethyl acetate extract
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Table 1: Zone of inhibition of the different C. macrostachyus extracts against selected human pathogens.
Pathogen
Zone of inhibition
Extract Antibiotic
1MeOH 2EtOAc 3BuOH A B
Escherichia coli 9.0 ± 1.1 12.2 ± 1.6 13.7 ± 1.4 20.1 ± 0.9 16.2 ± 0.8
Salmonella typhi 2.3 ± 1.87 16.0 ± 1.2 8.3 ± 1.5 22.1 ± 0.9 20.8 ± 0.8
Klebsiella pneumoniae 14.9 ± 1.3 10.7 ± 1.0 11.1 ± 1.9 19.7 ± 0.5 17.3 ± 0.9
Enterobacter aerogenes 10.8 ± 1.1 10.1 ± 0.6 10.8 ± 1.2 21.3 ± 0.5 18.6 ± 0.5
Listeria monocytogenes 0.0 ± 0.0 11.7 ± 1.3 0.0 ± 0.0 21.0 ± 0.8 18.3 ± 0.5
Candida albicans 12.0 ± 1.4 5.6 ± 1.0 0.0 ± 0.0 21.5 ± 0.7 13.4 ± 0.7
1MeOH, methanol extract.
2EtOAc, ethyl acetate extract.
3BuOH, isobutanol extract.
Zone of inhibition (diameter in mm) including diameter of the well (6mm). The experiments were carried out using triplicate samples. The results are from
three independent analyses and are the mean of 9 values (𝑛 = 9).
In negative control DMSO no inhibition was found.
For E. coli, S. typhi, K. pneumoniae, and E. aerogenes antibiotic A was amoxicillin and antibiotic B was ciprofloxacin.
For L. monocytogenes antibiotic control A was ampicillin and antibiotic control B was benzylpenicillin.
For C. albicans antibiotic control A was clotrimazole and antibiotic control B was cefotaxime.
induced the zone of inhibition between 10.1 ± 0.6mm and
16.0 ± 1.2mm against S. typhi, E. coli, K. pneumoniae, E.
aerogenes, and L. monocytogenes with slight antimicrobial
activity against C. albicans (zone of inhibition: 5.6± 1.0mm).
The isobutanol extract showed activity against S. typhi, E.
coli, K. pneumoniae, and E. aerogenes (zone of inhibition
between 8.3 ± 1.5mm and 13.7 ± 1.4mm) but did not show
any activity against L. monocytogenes and C. albicans. The
methanol extract was active against E. coli, K. pneumoniae,
E. aerogenes, and C. albicans with the zone of inhibition
between 9.0±1.1mmand 14.9±1.3mm.Themethanol extract
was not active against L. monocytogenes and had very low
activity against S. typhi (zone of inhibition: 2.3 ± 1.87mm).
All the extracts had quite equal activity against E. aerogenes
(zone of inhibition within 10.1 ± 0.6–10.8 ± 1.2mm). Against
S. typhi and L. monocytogenes the ethyl acetate extract was
the most active (zone of inhibition between 16.0 ± 1.2mm
and 11.7 ± 1.3mm, resp.). Against E. coli the isobutanol
extract possessed the highest activity (zone of inhibition:
12.2 ± 1.6mm). Against K. pneumoniae and C. albicans the
methanol extract was the most active (zones of inhibition:
14.9 ± 1.3mm and 12.0 ± 1.4mm, resp.). The antibiotic
controls were constantly high. The DMSO negative control
had no inhibitory activity.
For the active extracts MIC values were determined
(Table 2). For the methanol and isobutanol extracts theMICs
were 250–500mg/mL (results not shown). The methanol
extract against E. coli had MIC of 250mg/mL and against
K. pneumoniae, E. aerogenes, and C. albicans MIC was
500mg/mL, although the methanol extract induced the
narrowest zone of inhibition againstE. coli. Isobutanol extract
had MIC of 250mg/mL against both E. coli and S. typhi
and 500mg/mL against K. pneumoniae and E. aerogenes.
For the ethyl acetate extract the MICs were 125–250mg/mL
against all the studied pathogens except against C. albicans
(MIC of 500mg/mL). Lupeol had the lowest MIC for K.
pneumoniae (125mg/mL) and the highest MIC against C.
Table 2: Minimum inhibitory concentrations (MICs) (mg/mL)
of Croton macrostachyus EtOAc extract against selected human
pathogens.
Pathogen MIC
Escherichia coli 250
Klebsiella pneumoniae 125
Enterobacter aerogenes 250
Listeria monocytogenes 250
Candida albicans 500
albicans (500mg/mL). Against E. coli, S. typhi, E. aerogenes,
and L. monocytogenesMIC was 250mg/mL (Table 2).
3.2. NMR Analysis. NMR analysis of the fractionated and
crystallized ethyl acetate extract was carried out. The chemi-
cal shifts of the carbon atoms were compared to the literature
information (Table 3) [13]. The chemical shifts showed that
the purified compound was triterpene lupeol (Figure 1).
4. Discussion
When testing methanol extracts of C. macrostachyus leaves
and roots Wagate and colleagues [5] found MICs between
15.6 and 250mg/mL against three bacterial organisms, E. coli,
Bacillus cereus, and Pseudomonas aeruginosa. In the present
study the extracts from C. macrostachyus stem bark induced
growth inhibition against all the studied pathogens including
four gram-negative and one gram-positive bacteria withMIC
values of 125–250mg/mL.The results achieved in the present
study are in accordance with previous results carried out by
Suffredini et al. [11].
In the present study the antibiotic controls were con-
stantly high and some extracts induced inhibition which
almost reached the antibiotic level, when measured as zone
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Table 3: NMR analysis of the ethyl acetate extract from C.
macrostachyus stem bark1. Chemical shifts of the numbered carbon
atoms are shown. Numbering of the carbon atoms used is that of
triterpene framework.
Carbon number Sample (ppm) Lupeol (ppm)
28 18.22 17.97
20 151.20 150.88
29 109.54 109.31
3 79.23 78.94
17 43.22 42.95
5 55.51 55.25
9 50.65 50.38
19 48.20 47.94
18 48.51 48.24
14 43.04 42.78
8 41.04 40.78
4 39.07 38.81
1 38.92 38.67
13 38.26 38.00
22 40.20 39.96
7 34.49 34.23
16 35.80 35.54
15 27.66 27.41
21 30.06 29.80
23 28.20 27.95
2 27.62 27.35
10 37.38 37.11
12 25.35 25.08
11 21.14 20.89
30 19.52 19.28
6 18.50 18.28
26 16.19 15.94
25 16.33 16.09
24 15.59 15.35
27 14.76 14.51
1Obtained on a Bruker Avance AV400 spectrometer and referenced to the
solvent peak (CDCl
3
at 77.00 ppm).
of inhibition. Our results show that between the bacterial
strains there is variation in susceptibility to extracts. The
antimicrobial effect of the extract depends on the bacterial
strain and the extraction solvent. The broadest effect against
all the studied bacteria in a dose-dependent manner was
achieved by the ethyl acetate extract. However, against E.
coli the isobutanol extract and against K. pneumoniae and C.
albicans the methanol extract had even higher activity. The
main components of C. macrostachyus stem bark are lupeol,
betulin, and fatty acids [6]. Because of their solubility prop-
erties one could conclude that the isobutanol and methanol
extracts contained mixtures of these compounds. The active
components of the isobutanol and methanol extracts remain
here unknown.
Lupeol isolated from other plants has been reported
to inhibit the growth of several types of bacteria, fungi,
H
H
H
H
HO
H3C
H3C
H3C
CH2
CH3
CH3
CH3 CH3
Figure 1
and viral species [14–20]. In the present study lupeol was
isolated from C. macrostachyus stem bark by ethyl acetate
extraction followed by silica gel column chromatography.
The previous reports support our finding on antimicrobial
activity of lupeol. In our study, it was the first time when
lupeol was extracted from the stem bark of C. macrostachyus
and showed broad antimicrobial activity against several
important human pathogens E. coli, S. typhi, K. pneumoniae,
andC. albicanswith the novel finding againstE. aerogenes and
L. monocytogenes.
The present study gives scientific evidence for the use
of the extracts and especially lupeol from C. macrostachyus
stem bark as antimicrobial candidates against several human
pathogens. They could be utilized as preventive agents in
disinfectants or submitted to further process for drug or
dietary supplement development. The provision of safe and
effective traditional medicines could offer increasing access
to health care [1]. Various studies have established that herbal
medicines can be developed as safe, effective, and less costly
alternatives to the current medicines to treat certain bacterial
infections [21].
Abbreviations
DMSO: Dimethyl sulfoxide
NMR: Nuclear magnetic resonance
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3
: Deuterated chloroform
MIC: Minimal inhibitory concentration.
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